AstraZeneca buys Gracell to "enrich" cell therapy pipeline
AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company. The Cambridge, England-based pharmaceutical company...